- Exchange: Korea SE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Ilyang Pharmaceutical Co Ltd
+ Add to Watchlist007570:KS
31,900 KRW 700 2.24%As of 02:28:36 ET on 05/21/2013.
Snapshot for Ilyang Pharmaceutical Co Ltd (007570)
| Open: | 31,350 | Day's Range: | 31,300 - 32,200 | Volume: | 140,312 |
|---|---|---|---|---|---|
| Previous Close: | 31,200 | 52wk Range: | 20,050 - 38,550 | 1-Yr Rtn: | +50.55% |
Key Statistics for 007570
| Current P/E Ratio (ttm) | 261.4754 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. KOSPI | 1.1402 |
| Earnings Per Share (ttm) | 122.0000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 570,858.69 |
| Shares Outstanding (M) | 17.90 |
| 30 Day Average Volume | 200,381 |
| Price/Book (mrq) | 3.0022 |
| Price/Sale (ttm) | 3.6946 |
| Dividend Indicated Gross Yield | 0.31% |
| Cash Dividend (KRW) | 100.0000 |
| Last Dividend | 03/28/2013 |
| 5 Year Dividend Growth | 0.00% |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 007570
Company Profile & Key Executives for 007570
Il Yang Pharmaceutical Co., Ltd. manufactures a wide range of drugs acting on the digestive system, respiratory system, and circulatory system. The Company also produces antipyretic, analgesic, anti-inflammatory, and nutritional agents, tranquilizers, health food and drinks, insecticides, therapeutic agents for liver and kidney disease.
| Chung Do-EonChairman/Co-Rep Director | Kim Dong-YounPresident/Co-Rep Director |
| Chung Yoo SukManaging Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
007570 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page